These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27727005)

  • 21. Long-term improvements in insulin prescribing habits and glycaemic control in medical inpatients associated with the introduction of a standardized educational approach.
    Ena J; Casañ R; Lozano T; Leach A; Algado JT; Navarro-Diaz FJ
    Diabetes Res Clin Pract; 2009 Aug; 85(2):159-65. PubMed ID: 19520451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with Prolonged Inaction in the hypoglycaemic treatment in people with non-insulin dependent Type 2 Diabetes and elevated glycated haemoglobin: A registry-based cohort study.
    Goderis G; Vaes B; Van den Akker M; Elli S; Mathieu C; Buntinx F; Henrard S
    Prim Care Diabetes; 2017 Oct; 11(5):482-489. PubMed ID: 28648964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 24. Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey.
    Cuddihy RM; Philis-Tsimikas A; Nazeri A
    Diabetes Educ; 2011; 37(1):111-23. PubMed ID: 21131599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin initiation status of primary care physicians in Turkey, barriers to insulin initiation and knowledge levels about insulin therapy: A multicenter cross-sectional study.
    Ates E; Set T; Saglam Z; Tekin N; Karatas Eray I; Yavuz E; Sahin MK; Selcuk EB; Cadirci D; Cubukcu M
    Prim Care Diabetes; 2017 Oct; 11(5):430-436. PubMed ID: 28579057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
    Morales J; Assumpcao-Morales M
    Diabetes Obes Metab; 2018 Aug; 20(8):1809-1811. PubMed ID: 29658190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).
    Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Torffvit O; Pehrsson NG
    Prim Care Diabetes; 2015 Feb; 9(1):15-22. PubMed ID: 25175385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
    Neumark AS; Brudin L; Neumark T
    Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical coaching in primary care: Capable of improving control in patients with type 2 diabetes mellitus?
    González-Guajardo EE; Salinas-Martínez AM; Botello-García A; Mathiew-Quiros Á
    Prim Care Diabetes; 2016 Jun; 10(3):171-8. PubMed ID: 26615758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [National practice guideline for diabetes. Managing your diabetic patient properly].
    Stiefelhagen P
    MMW Fortschr Med; 2002 Jul; 144(27-28):4-8, 10. PubMed ID: 12198877
    [No Abstract]   [Full Text] [Related]  

  • 34. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".
    Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK
    J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study.
    Peyrot M; Barnett AH; Meneghini LF; Schumm-Draeger PM
    Diabetes Obes Metab; 2012 Dec; 14(12):1081-7. PubMed ID: 22726104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
    McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD
    J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
    Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
    Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to treatment 1: How is type 2 diabetes actually treated?
    Bloomgarden ZT
    J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
    [No Abstract]   [Full Text] [Related]  

  • 40. [Timely commencement of insulin in type 2 diabetes: benefits and risks].
    Winkler G
    Orv Hetil; 2014 Feb; 155(7):255-61. PubMed ID: 24509354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.